Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Treatment for women news


From To
Option B+: Understanding perspectives and experiences of women living with HIV

Option B+ is a prevention of vertical transmission approach for expectant mothers living with HIV in which women are immediately offered treatment for life regardless of their CD4 count. This approach offers advantages such as protection of partner(s) and (unborn) child, as well as benefits to the woman's health, but also carries with it risks. In the attached publication, GNP+ and ICW report on the results of 8 different focus group discussions that discussed these issues in Uganda and Malawi.

12 April 2013
HIV Drug Not Tied to Premature Births

Pregnant HIV-infected women treated with a lopinavir/ritonavir (Kaletra)-based antiretroviral regimen are at no greater risk of delivering a preterm baby than similar pregnant women given an efavirenz (Sustiva)-based treatment, researchers said here.

10 March 2013
MedPage Today
Are hospitals safe for women living with HIV?

A human rights investigation conducted by the Namibia Women’s Health Network, Harvard Law School’s Human Rights Program, and Northeastern University School of Law found that women living with HIV are often mistreated in hospital settings. This report will be launched at the AIDS conference this week in Washington DC.

25 July 2012
How the Supreme Court's Obamacare Ruling Fails Poor Black Women With HIV

By allowing states to choose whether or not they will expand Medicaid, the Supreme Court may have set back the fight against HIV/AIDS among poor women of color who desperately need treatment.

03 July 2012
HIV Worsens Bone Loss After Menopause

Compared to a control group, postmenopausal women with HIV infection had higher rates of bone loss and could well have a higher risk for fracture as they age, according to the researchers who conducted the study.

03 January 2012
Medscape (requires free registration)
Studies in Post-Menopausal Women Reveal Potentially Higher Biological HIV Risk, as Well as Possible Tenofovir Concerns

A little light from CROI 2011 has shone into the dark corners of research into aging women with HIV/AIDS. Two oral presentations compared HIV risk in pre-menopausal versus post-menopausal women.

01 March 2011
The BodyPro
US: Best HIV Treatment Practices Among Women Receiving ADAP

Women enrolled in AIDS Drug Assistance Programs (ADAPs) in California, New York and Illinois were more likely to be taking antiretroviral (ARV) medication according to treatment guidelines than women not on ADAPs. These findings, published in the March 1 issue of the Journal of Acquired Immune Deficiency Syndromes, hold up even when the analysis includes women with public or private health insurance.

16 February 2011
Registry Sees No Increased Overall Birth Defect Risk With First-Trimester Antiretrovirals

Ongoing international reporting to the Antiretroviral Pregnancy Registry discerned no greater risk of birth defects among women taking antiretrovirals during the first trimester than among women taking antiretrovirals later in pregnancy.

14 January 2011
Program Reduces Cervical Cancer Deaths Among HIV-infected Women In Zambia

A new study undertaken in Zambia shows that, using setting-appropriate human resources and technology, morbidity and mortality from cervical cancer among HIV-infected women can be reduced...

15 December 2010
HIV / AIDS News From Medical News Today
American College of Obstetricians and Gynecologists Issues Guidelines on Care for HIV-Infected Women

The guidelines cover the recommended health screenings, counseling, and routine gynecologic care for women with HIV/AIDS.

23 November 2010

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.